IRIS
BERTELE', Anna
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 584
EU - Europa 354
AS - Asia 331
Continente sconosciuto - Info sul continente non disponibili 4
AF - Africa 1
Totale 1.274
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 577
CN - Cina 250
IE - Irlanda 142
SE - Svezia 131
TR - Turchia 35
SG - Singapore 27
IT - Italia 20
FI - Finlandia 17
DE - Germania 10
IN - India 8
BE - Belgio 7
CA - Canada 7
RU - Federazione Russa 6
NL - Olanda 5
EU - Europa 4
RO - Romania 4
GB - Regno Unito 3
ID - Indonesia 3
IR - Iran 3
KR - Corea 3
BG - Bulgaria 2
HU - Ungheria 2
UA - Ucraina 2
CI - Costa d'Avorio 1
CZ - Repubblica Ceca 1
FR - Francia 1
JP - Giappone 1
NO - Norvegia 1
PH - Filippine 1
Totale 1.274
Salva come PNG Salva come JPEG
Città #
Chandler 208
Dublin 142
Ashburn 48
Nanjing 48
Shanghai 42
Dearborn 40
Beijing 33
Izmir 30
Princeton 25
Ann Arbor 18
Singapore 18
Wilmington 16
Shenyang 14
Nanchang 13
Changsha 12
Helsinki 12
Jiaxing 12
Jinan 11
Tianjin 11
New York 10
San Mateo 9
Hefei 8
Pune 8
Kunming 7
Hebei 6
Los Angeles 6
Ottawa 6
Chengdu 5
Jacksonville 5
Kocaeli 5
Norwalk 5
Brussels 4
Fryazino 4
Hangzhou 4
Ningbo 4
Timisoara 4
Woodbridge 4
Andover 3
Bandung 3
Bremen 3
Cambridge 3
Geumcheon-gu 3
Milan 3
Shijiazhuang 3
Zanjan 3
Arnhem 2
Bologna 2
Budapest 2
Castelnuovo Rangone 2
Chongqing 2
Grafing 2
Jiangnong 2
Montegaldella 2
Moscow 2
Opera 2
Parma 2
Redwood City 2
Rockville 2
Seattle 2
Sofia 2
Taiyuan 2
Baotou 1
Borås 1
Des Moines 1
Edinburgh 1
Glasgow 1
Guangzhou 1
Harbin 1
Huizen 1
Lanzhou 1
Lottstetten 1
Olomouc 1
Oslo 1
Quezon City 1
Quzhou 1
Redmond 1
Toronto 1
Wenzhou 1
Wuhan 1
Totale 931
Salva come PNG Salva come JPEG
Nome #
Kleine-Levin syndrome: the contribution of PET scan and hydrogen breath test for small intestinal bacterial overgrowth 83
Endocrine cell replacement of oxyntic glands in Zollinger-Ellison syndrome: a role for female sex hormones? 66
P.02.18: Non Invasive Diagnosis of Upper Gi Diseases in a Primary Care Setting: A Study on 1,900 Patients 62
Organization of a high quality endoscopic unit: The experience of parma 60
OC1.09.3 USEFULNESS OF GASTROPANEL FOR SCREENING OF ATROPHIC GASTRITIS IN PATIENTS WITH AUTOIMMUNE THYROID DISEASES 60
P.01.14: Overweight and Obesity as Risk Factors for Gerd Outcome: A 10 Years Study on a Gerd Population of 365 Patients 58
Gastrin 17 in Singling Out Patients with Different Patterns of Refluxate: A Pilot Study Using Impedance-pH as Reference Standard 56
Gastroesophageal reflux disease in celiac patients: Preliminary results in 35 consecutive patients 55
P.01.13: Gastrin-17 as a Non-Invasive Marker for Gerd: A Prospective Study on Sample of 777 Consecutive Patients 54
PA.28 SERUM PEPSINOGEN I AS NON INVASIVE MARKER OF GASTRIC ACID SECRETION 54
Serum pepsinogen II for early assessment of success of H. pylori eradication 54
P.01.7: Efficacy of PPIS and H-2 Blockers Therapy on Acid Suppression Assessed by Gastrin-17 and Pepsinogen I Serum Levels Determination in Gerd Patients 53
OC.18.1 ARE ALL PATIENTS WITH HISTOLOGICAL DIAGNOSIS OF ATROPHIC GASTRITIS REALLY AT RISK OF DEVELOPING GASTRIC CANCER? ASSESSMENT OF GASTRIC ACID PRODUCTION BY CORRELATION BETWEEN MAXIMAL ACID OUTPUT AND PEPSINOGEN I 52
P.01.11: Gastrin 17 in Singling out Patients with Different Pattern of Gastroesophageal Reflux: A Pilot Study using PH-Impedance as Reference Standard 51
Gastro panel® for detection of atrophic gastritis: The “Parma model” 50
S2067 A Comparison Between Lactose Breath Test and a Quick Test On Duodenal Biopsies for Lactase Deficiency, in Patients with a Self Reported Lactose Intolerance 49
P.01.8: Gerd Risk Factors in Different Epidemiological Settings: Results from a Structured Questionnaire on a Sample of 545 People 49
Sa1862 Are All Patients With Histological Diagnosis of Atrophic Gastritis Really At Risk of Developing Gastric Cancer? Assessment of Gastric Acid Production by Correlation Between Maximal Acid Output and Pepsinogen I 49
P.02.1: Individual Assessment of Gastric Acid Production by Means of a Non-Invasive Test: Relationship Between Maximal Acid Output and Serum Pepsinogen I Levels in Patients with Different Upper GI Diseases 49
DO PREBIOTICS RELIEVE CONSTIPATION-PREDOMINANT IRRITABLE BOWEL SYNDROME (IBS-C) SYMPTOMS? A RANDOMIZED SINGLE BLINDED STUDY 46
P.04.9 DIAGNOSIS OF CHRONIC ATROPHIC GASTRITIS IN PRIMARY CARE SETTING BY MEANS OF GASTROPANEL®: A POPULATION STUDY ON 10,000 CONSECUTIVE PATIENTS 43
Non invasive diagnosis of upper GI disease in a primary care setting: A study on 1900 patients 42
Serum pepsinogen II and gastrin-17 as markers of NSAIDs gastropathy 40
CORRELATION BETWEEN LACTOSE H2-BREATH TEST AND CLINICAL DATA: IS IT POSSIBLE TO SELECT PATIENTS WHO NEED LACTOSE BREATH TEST? 37
Raising public awareness of GI disease: An innovative strategy for a national campaign 28
Totale 1.300
Salva come PNG Salva come JPEG
Categoria #
all - tutte 5.170
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 5.170
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020247 84 36 3 0 6 44 28 10 12 18 3 3
2020/202126 1 1 5 0 1 0 3 2 4 6 3 0
2021/2022106 1 0 0 3 13 2 1 8 5 12 9 52
2022/2023591 46 67 51 55 38 71 1 49 186 5 21 1
2023/2024207 5 27 4 4 21 51 8 18 16 11 20 22
2024/20251 1 0 0 0 0 0 0 0 0 0 0 0
Totale 1.300